Your browser doesn't support javascript.
loading
Risk of hypertension and treatment on out-of-hospital cardiac arrest incidence: A case-control study.
Kim, Jooyeong; Cho, Sung-Il; Park, Jong-Hak; Song, Juhyun; Ahn, Sejoong; Cho, Hanjin; Moon, Sungwoo.
Afiliación
  • Kim J; Department of Emergency Medicine, Korea University Ansan Hospital, Ansan, Gyeonggi-do, Republic of Korea.
  • Cho SI; Department of Public Health Sciences, Graduate School of Public Health, Seoul National University, Seoul, Republic of Korea.
  • Park JH; Department of Public Health Sciences, Graduate School of Public Health, Seoul National University, Seoul, Republic of Korea.
  • Song J; Institute of Health and Environment, Seoul National University, Seoul, Republic of Korea.
  • Ahn S; Department of Emergency Medicine, Korea University Ansan Hospital, Ansan, Gyeonggi-do, Republic of Korea.
  • Cho H; Department of Emergency Medicine, Korea University Ansan Hospital, Ansan, Gyeonggi-do, Republic of Korea.
  • Moon S; Department of Emergency Medicine, Korea University Ansan Hospital, Ansan, Gyeonggi-do, Republic of Korea.
Medicine (Baltimore) ; 101(22): e29161, 2022 Jun 03.
Article en En | MEDLINE | ID: mdl-35665725
ABSTRACT
ABSTRACT Hypertension (HTN) is a high risk factor for major cardiovascular adverse events. This study aimed to investigate the effect of HTN risk on out-of-hospital cardiac arrest (OHCA) incidence and determine whether the effect of HTN on OHCA incidence differs according to antihypertensive medication.This case-control study used the Korean Cardiac Arrest Resuscitation Consortium and Korean Community Health Survey (CHS). Cases were defined as emergency medical service-treated adult OHCA patients presumed to have a cardiac etiology from 2015 to 2017. Patients without information on HTN diagnosis were excluded from the study. The Korean CHS database's controls were matched at a 12 ratio with strata, including age, gender, and county of residence. Multivariable conditional logistic regression analysis was conducted to estimate HTN risk and antihypertensive treatment on OHCA incidence,A total of 2633 OHCA patients and 5266 community-based controls were enrolled in this study. Among them, 1176 (44.7%) patients and 2049 (38.9%) controls were diagnosed with HTN. HTN was associated with an increased risk of OHCA (adjusted odds ratio [AOR] 1.19 [1.07-1.32]). On comparing HTN with or without the antihypertensive treatment group with the non-HTN-diagnosed group (as a reference), the HTN without treatment group had the highest AOR (95% confidence interval) (3.41 [2.74-4.24]). The AOR in the HTN treatment group was reduced to that in the non-HTN-diagnosed group (0.96 [0.86-1.08]).HTN increased OHCA risk, and the HTN without treatment group had the highest OHCA risk. Conversely, OHCA risk decreased to the non-HTN-diagnosed group level with HTN treatment.
Asunto(s)

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Reanimación Cardiopulmonar / Servicios Médicos de Urgencia / Paro Cardíaco Extrahospitalario / Hipertensión Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Límite: Adult / Humans Idioma: En Revista: Medicine (Baltimore) Año: 2022 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Reanimación Cardiopulmonar / Servicios Médicos de Urgencia / Paro Cardíaco Extrahospitalario / Hipertensión Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Límite: Adult / Humans Idioma: En Revista: Medicine (Baltimore) Año: 2022 Tipo del documento: Article